tradingkey.logo
tradingkey.logo
Search

Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update

PR NewswireSep 9, 2026 12:56 PM
facebooktwitterlinkedin
View all comments0

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 


Defense company Covenant has come out of stealth

Kristen Scholer delivers the pre-market update on September 9th

  • Moonwalk Bio says recent funding will advance RNAi development.
    • The startup says its treatments have demonstrated reductions in body weight and fat mass while preserving lean muscle mass.
    • Moonwalk's lead development candidate is expected to enter first-in-human clinical studies in late 2027.
    • CEO Dr. Alex Aravanis will join NYSE Live to discuss the path forward for treatments.
  • Defense company Covenant opens a 105,000 square-foot factory in Texas.
    • The company introduced Anthem, a heavy-payload, long-range weapon system.
    • Covenant announced more than $250 million in funding across three rounds, with Andreesen Horowitz and Lightspeed among its backers.
  • ICE Brent Crude tops $100 a barrel amid the ongoing Middle East conflict.
    • This marks the first time the benchmark has reached triple digits since July.
    • The rise in oil prices comes ahead of a pair of inflation reading, which are set to come out later this week.

Opening Bell
Oracle (NYSE: ORCL) brings together customers for a unique experience

Closing Bell
LabCorp (NYSE: LH) celebrates 35 years as a listed company

For market insights, IPO activity, and today's opening bell, download the NYSE TV App and check out the NYSE YouTube: TV.NYSE.com and YouTube.com/@NYSEofficial


XTEND AI Robotics at NYSE on September 8

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.